Resultados de la búsqueda 41-50 of 6471 for Lymphangiogenesis

  1. Mayo Clinic Digestive Diseases Physician Update - April 2025

    Page 1.

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer cells in ...

  3. Mayo Clinic Cancer Physician Update - January 2025

    Page 1.

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to evaluate a low-cost Contrast Enhanced Digital Mammogram (CEDM) protocol as a supplemental screening method to standard ...

  5. Mayo Clinic Physician Update - August 2025

    Page 1.

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Create a registry of patients having or at risk for cancer of the liver or bile ducts (also known as hepatocellular carcinoma or cholangiocarcinoma), or ...

  7. Untitled

    Page 1.

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Olaparib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as temozolomide, work in ...